Cargando…
A vesicular stomatitis virus glycoprotein epitope-incorporated oncolytic adenovirus overcomes CAR-dependency and shows markedly enhanced cancer cell killing and suppression of tumor growth
Utility of traditional oncolytic adenovirus (Ad) has been limited due to low expression of coxsackie and adenovirus receptor (CAR) in cancer cells which results in poor infectivity of Ads. Here with an aim of improving the efficiency of Ad's entry to the cell, we generated a novel tropism-expan...
Autores principales: | Yoon, A-Rum, Hong, Jinwoo, Yun, Chae-Ok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741496/ https://www.ncbi.nlm.nih.gov/pubmed/26430798 |
Ejemplares similares
-
Hepatocellular carcinoma-targeting oncolytic adenovirus overcomes hypoxic tumor microenvironment and effectively disperses through both central and peripheral tumor regions
por: Yoon, A-Rum, et al.
Publicado: (2018) -
Challenges and progress toward tumor-targeted therapy by systemic delivery of polymer-complexed oncolytic adenoviruses
por: Thambi, Thavasyappan, et al.
Publicado: (2022) -
Overcoming the limitations of locally administered oncolytic virotherapy
por: Hong, JinWoo, et al.
Publicado: (2019) -
ErbB3-Targeting Oncolytic Adenovirus Causes Potent Tumor Suppression by Induction of Apoptosis in Cancer Cells
por: Jung, Bo-Kyeong, et al.
Publicado: (2022) -
Transmembrane biogenesis of the vesicular stomatitis virus glycoprotein
Publicado: (1979)